J jgp Member Nov 16, 2016 #1 Barb; this is the new COPD drug in trials. Its Daliresp with a pde3 inhibitor. Here is a good read www.mdedge.com/chestphysician/article/113754/pulmonology/rpl-554-adds-short-acting-drugs-benefits-copd I just like to know how long before market.
Barb; this is the new COPD drug in trials. Its Daliresp with a pde3 inhibitor. Here is a good read www.mdedge.com/chestphysician/article/113754/pulmonology/rpl-554-adds-short-acting-drugs-benefits-copd I just like to know how long before market.
B barbara Pioneer Founding member Nov 16, 2016 #2 Good question. I also wonder if it will have the same side effects that Daliresp had on so many patients.
Good question. I also wonder if it will have the same side effects that Daliresp had on so many patients.
J jgp Member Nov 16, 2016 #3 no side effects at all barbara said: Good question. I also wonder if it will have the same side effects that Daliresp had on so many patients. Click to expand... Barb; read trial results there were no, nada, side effects because it is inhaled not swallowed.
no side effects at all barbara said: Good question. I also wonder if it will have the same side effects that Daliresp had on so many patients. Click to expand... Barb; read trial results there were no, nada, side effects because it is inhaled not swallowed.